Target intelligence / Profile preview

Steroid transmembrane transporter SLC22A24 (SLC22A24)

Target
SLC22A24
Molecular classification
Transporter, Transmembrane protein, Organic anion/dicarboxylate exchanger, Solute carrier (SLC) family
01

Overview

SLC22A24 (Steroid transmembrane transporter SLC22A24) is a member of the solute carrier (SLC) family 22, specifically mediating the transport of organic ions, including conjugated steroids and bile acids, across cell membranes as a renal transmembrane organic anion/dicarboxylate exchanger. It is mainly expressed in the kidney, where it participates in the reabsorption of steroid conjugates such as estradiol-17beta-glucuronide, androstanediol glucuronide, and estrone 3-sulfate, as well as bile acids like taurocholate and glycocholate. SLC22A24 plays a crucial role in modulating steroid hormone homeostasis, with genetic variants linked to altered metabolite levels and disease predisposition, including cardiovascular disease and acne. As an orphan transporter, it represents a promising pharmacological target for conditions related to steroid imbalance. No direct approved therapeutics target SLC22A24 at present, but its function and associations suggest potential utility in future drug development or biomarker discovery.

Other names
SLC22A24Solute carrier family 22 member 24NET46MGC34821Steroid transmembrane transporter SLC22A24C9JC66Q8N4F4
02

Mechanism of action

For investigational drugs or modulators (none currently approved): Inhibition or enhancement of transporter function could modify cellular uptake of steroid conjugates or bile acids. Mechanism would typically involve binding and allosteric regulation or competitive inhibition of transporter activity.

03

Biological functions

Transport of conjugated steroids (including estradiol-17beta-glucuronide, androstanediol glucuronide, estrone 3-sulfate)Renal reabsorption of organic anions and bile acidsRegulation of steroid homeostasis
04

Disease associations

Cardiovascular disease (associated with SLC22A24 genetic variants impacting steroid levels)Acne (linked via phenome-wide association studies with steroid metabolism)Carboxypeptidase N deficiency (reported association, though likely minor)Other conditions affecting steroid hormone imbalance
05

Safety considerations

Potential disruption of steroid and bile acid homeostasis if SLC22A24 activity is modulated excessivelyRisk of off-target effects via other organic anion/bile acid pathways
06

Interacting drugs

No clinically approved drugs known to directly target SLC22A24 as of current literature and major databases. SLC22A24’s transportable substrates include steroid conjugates and bile acids; exploration for modulating agents may be ongoing.
07

Biomarkers

Genetic variants of SLC22A24 associated with altered steroid metabolite levels serve as potential biomarkers for disorders of steroid metabolism and could indicate disease risk or therapeutic responseExpression levels of SLC22A24 in kidney tissue

Beyond the preview

Go deeper on Steroid transmembrane transporter SLC22A24 (SLC22A24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Steroid transmembrane transporter SLC22A24 (SLC22A24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call